Rik van Mol

Rik van Mol, Vice President of R&D Strategy at Veeva Systems


eTMF Adoption a Year After the MHRA Update

The pharma industry has had a year to address MHRA’s April 2014 update to the definition of a critical GCP inspection finding to include trial master files(TMFs) that are “not readily available or accessible”. How has it fared? Rik van Mol reports.